These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1430194)

  • 21. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
    Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
    Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited p53 gene mutations in breast cancer.
    Sidransky D; Tokino T; Helzlsouer K; Zehnbauer B; Rausch G; Shelton B; Prestigiacomo L; Vogelstein B; Davidson N
    Cancer Res; 1992 May; 52(10):2984-6. PubMed ID: 1581912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex replication error causes p53 mutation in a Li-Fraumeni family.
    Strauss EA; Hosler MR; Herzog P; Salhany K; Louie R; Felix CA
    Cancer Res; 1995 Aug; 55(15):3237-41. PubMed ID: 7614454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype.
    Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS
    Carcinogenesis; 2006 Sep; 27(9):1860-6. PubMed ID: 16597646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mutational spectra of gene p53 in different types of tumors].
    Glazko GV; Rogozin IB; Sozinov AA
    Tsitol Genet; 1999; 33(3):14-20. PubMed ID: 10474858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
    Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME
    Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: a Li-Fraumeni syndrome p53 mutation.
    Malkin D; Friend SH
    Science; 1993 Feb; 259(5097):878. PubMed ID: 8438145
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutations in the TP53 gene.
    Eeles RA
    Cancer Surv; 1995; 25():101-24. PubMed ID: 8718514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
    Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
    Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 mutations in breast cancer.
    Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
    Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.